Form of administration secured against misuse
Abstract
Claim 1: A thermoformed dosage form without abuse-proof extrusion, characterized in that it contains, in addition to one or more active substances susceptible to abuse (A) and optionally physiologically acceptable auxiliary substances (B), at least one synthetic or natural polymer (C) and optionally at least one wax (D), the component (C) and the component optionally present (D) each having a hardness of at least 500 N. Claim 2: A dosage form according to claim 1m, characterized in that it has the tablet form. Claim 11: A dosage form according to one of claims 1 to 10, characterized in that the active ingredient (A) is at least one active ingredient selected from the group comprising opioids, tranquilizers, stimulants, barbiturates and other narcotics. Claim 12: A dosage form according to one of claims 1-11 characterized in that it additionally contains at least one of the following components a) -f): (a) at least one substance that irritates the nostrils and / or pharynx, (b) at least one viscosifying agent, which, with the help of a minimum necessary amount of an aqueous liquid forms a gel with the extract obtained in the form of dosage, which preferably continues to be visually distinguishable when added to an additional amount of aqueous liquid; (c) at least one antagonist for the active substance or active substances susceptible to abuse; (d) at least one emetic; (e) at least one dye as an aversive agent, (f) at least one bitter substance.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
293 members in 32 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 10336400 | Germany | A | |
| 10336400 | Germany | A | |
| 103364005 | – | – | – |
| DE2003136400 | – | – | – |
Members293
| Document | Office | Kind | |
|---|---|---|---|
| US2005031546A1 | United States of America | A1 | |
| AU2004264666A1 | Australia | A1 | |
| AU2004264667A1 | Australia | A1 | |
| CA2534925A1 | Canada | A1 | |
| CA2534932A1 | Canada | A1 | |
| WO2005016313A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2005016314A1 | World Intellectual Property Organization (WIPO) | A1 | |
| DE10336400A1 | Germany | A1 | |
| CL2004002016A1 | Chile | A1 | |
| CL2004002017A1 | Chile | A1 | |
| PE20050353A1 | Peru | A1 | |
| AU2004308653A1 | Australia | A1 | |
| CA2551231A1 | Canada | A1 | |
| WO2005063214A1 | World Intellectual Property Organization (WIPO) | A1 | |
| DE10361596A1 | Germany | A1 | |
| AR045352A1This record | Argentina | A1 | |
| AR045353A1 | Argentina | A1 | |
| US2005236741A1 | United States of America | A1 | |
| WO2005102286A1 | World Intellectual Property Organization (WIPO) | A1 | |
| DE102004020220A1 | Germany | A1 | |
| PE20050728A1 | Peru | A1 | |
| PE20050814A1 | Peru | A1 | |
| AR046994A1 | Argentina | A1 | |
| US2006002859A1 | United States of America | A1 | |
| WO2006002883A1 | World Intellectual Property Organization (WIPO) | A1 | |
| DE102004032051A1 | Germany | A1 | |
| NO20061054L | Norway | L | |
| NO20061055L | Norway | L | |
| PE20060195A1 | Peru | A1 | |
| EP1658054A1 | European Patent Office (EPO) | A1 | |
| EP1658055A1 | European Patent Office (EPO) | A1 | |
| IL173478D0 | Israel | D0 | |
| KR20060069832A | Republic of Korea | A | |
| AR049083A1 | Argentina | A1 | |
| IL173558D0 | Israel | D0 | |
| PE20060482A1 | Peru | A1 | |
| AU2006210145A1 | Australia | A1 | |
| CA2595954A1 | Canada | A1 | |
| DE102005005446A1 | Germany | A1 | |
| WO2006082099A1 | World Intellectual Property Organization (WIPO) | A1 | |
| ECSP066345A | Ecuador | A | |
| ECSP066346A | Ecuador | A | |
| US2006193782A1 | United States of America | A1 | |
| US2006193914A1 | United States of America | A1 | |
| AR049839A1 | Argentina | A1 | |
| EP1699440A1 | European Patent Office (EPO) | A1 | |
| IL176296D0 | Israel | D0 | |
| BRPI0413318A | Brazil | A | |
| BRPI0413361A | Brazil | A | |
| CN1863513A | China | A | |
| CN1863514A | China | A | |
| TW200640501A | Taiwan Province of China | A | |
| PE20061087A1 | Peru | A1 | |
| US2007003616A1 | United States of America | A1 | |
| EP1740156A1 | European Patent Office (EPO) | A1 | |
| JP2007501201A | Japan | A | |
| JP2007501202A | Japan | A | |
| KR20070017459A | Republic of Korea | A | |
| CN1917862A | China | A | |
| US2007048228A1 | United States of America | A1 | |
| IL178787D0 | Israel | D0 | |
| EP1658055B1 | European Patent Office (EPO) | B1 | |
| EP1765298A1 | European Patent Office (EPO) | A1 | |
| MXPA06001452A | Mexico | A | |
| AT356618T | Austria | T | |
| ATE356618T1 | Austria | T1 | |
| ZA200601087B | South Africa | B | |
| DE502004003234D1 | Germany | D1 | |
| HK1095081A1 | Hong Kong, China | A1 | |
| HK1095082A1 | Hong Kong, China | A1 | |
| ZA200601090B | South Africa | B | |
| CN1980643A | China | A | |
| AR054328A1 | Argentina | A1 | |
| EP1658054B1 | European Patent Office (EPO) | B1 | |
| JP2007516998A | Japan | A | |
| DK1658055T3 | Denmark | T3 | |
| IL180335D0 | Israel | D0 | |
| AT365545T | Austria | T | |
| ATE365545T1 | Austria | T1 | |
| PT1658055E | Portugal | E | |
| HRP20070272T3 | Croatia | T3 | |
| CN101010071A | China | A | |
| DE502004004205D1 | Germany | D1 | |
| US2007183979A1 | United States of America | A1 | |
| US2007183980A1 | United States of America | A1 | |
| MX2007009393A | Mexico | A | |
| HK1099511A1 | Hong Kong, China | A1 | |
| PL1658055T3 | Poland | T3 | |
| SI1658055T1 | Slovenia | T1 | |
| PT1658054E | Portugal | E | |
| HK1100639A1 | Hong Kong, China | A1 | |
| DK1658054T3 | Denmark | T3 | |
| EP1842533A2 | European Patent Office (EPO) | A2 | |
| EP1845956A1 | European Patent Office (EPO) | A1 | |
| SI1658054T1 | Slovenia | T1 | |
| NO20074412L | Norway | L | |
| EP1842533A3 | European Patent Office (EPO) | A3 | |
| ES2285497T3 | Spain | T3 | |
| KR20070111510A | Republic of Korea | A | |
| JP2007533692A | Japan | A |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| RefusalFC | FC |
Numbers
- Publication, DOCDB
- 045352
- Publication, EPODOC
- AR045352
- Application
- 102829
- Application, DOCDB
- P040102829
- Application, EPODOC
- AR2004P102829
Titles2
- Spanish
- FORMA DE DOSIFICACION A PRUEBA DE ABUSO
- English
- ABUSE PROOF DOSAGE FORM
Classification
- CPC, 18
- A61K31/135
- A61K9/20
- A61K9/2031
- A61K9/205
- A61K31/515
- A61K31/5513
- A61K9/2095
- A61K31/485
- A61P25/00
- A61P25/04
- A61P25/22
- A61P25/30
- A61K9/0053
- A61K9/2027
- A61K9/2054
- A61K9/2068
- A61K47/10
- A61K9/2013
- IPC, 4
- A61K9 20
- A61K31 485
- A61K31 515
- A61K31 5513